Logo image of LUNR

INTUITIVE MACHINES INC (LUNR) Stock Fundamental Analysis

NASDAQ:LUNR - Nasdaq - US46125A1007 - Common Stock - Currency: USD

9.085  +0.1 (+1.06%)

After market: 9.0898 +0 (+0.05%)

Fundamental Rating

3

LUNR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 67 industry peers in the Aerospace & Defense industry. LUNR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, LUNR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year LUNR has reported negative net income.
LUNR had a negative operating cash flow in the past year.
LUNR had negative earnings in 4 of the past 5 years.
LUNR had negative operating cash flow in 4 of the past 5 years.
LUNR Yearly Net Income VS EBIT VS OCF VS FCFLUNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

LUNR's Return On Assets of -59.17% is on the low side compared to the rest of the industry. LUNR is outperformed by 85.07% of its industry peers.
Industry RankSector Rank
ROA -59.17%
ROE N/A
ROIC N/A
ROA(3y)-6.39%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LUNR Yearly ROA, ROE, ROICLUNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

Looking at the Gross Margin, with a value of 3.25%, LUNR is doing worse than 82.09% of the companies in the same industry.
LUNR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LUNR Yearly Profit, Operating, Gross MarginsLUNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 50 -50 -100

4

2. Health

2.1 Basic Checks

LUNR does not have a ROIC to compare to the WACC, probably because it is not profitable.
LUNR has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, LUNR has an improved debt to assets ratio.
LUNR Yearly Shares OutstandingLUNR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
LUNR Yearly Total Debt VS Total AssetsLUNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

LUNR has an Altman-Z score of 2.21. This is not the best score and indicates that LUNR is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.21, LUNR is not doing good in the industry: 68.66% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 2.21
ROIC/WACCN/A
WACC10.11%
LUNR Yearly LT Debt VS Equity VS FCFLUNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 -200M -400M -600M -800M -1B

2.3 Liquidity

LUNR has a Current Ratio of 4.39. This indicates that LUNR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of LUNR (4.39) is better than 86.57% of its industry peers.
LUNR has a Quick Ratio of 4.39. This indicates that LUNR is financially healthy and has no problem in meeting its short term obligations.
LUNR's Quick ratio of 4.39 is amongst the best of the industry. LUNR outperforms 95.52% of its industry peers.
Industry RankSector Rank
Current Ratio 4.39
Quick Ratio 4.39
LUNR Yearly Current Assets VS Current LiabilitesLUNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M 200M 250M

6

3. Growth

3.1 Past

LUNR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -307.95%.
The Revenue has grown by 186.72% in the past year. This is a very strong growth!
LUNR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 46.48% yearly.
EPS 1Y (TTM)-307.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-175.86%
Revenue 1Y (TTM)186.72%
Revenue growth 3Y46.48%
Revenue growth 5YN/A
Sales Q2Q%21.51%

3.2 Future

The Earnings Per Share is expected to grow by 16.43% on average over the next years. This is quite good.
The Revenue is expected to grow by 23.87% on average over the next years. This is a very strong growth
EPS Next Y103.64%
EPS Next 2Y43.69%
EPS Next 3Y22.46%
EPS Next 5Y16.43%
Revenue Next Year17.83%
Revenue Next 2Y29.49%
Revenue Next 3Y23.57%
Revenue Next 5Y23.87%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LUNR Yearly Revenue VS EstimatesLUNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
LUNR Yearly EPS VS EstimatesLUNR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2 -4

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LUNR. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 24.81, the valuation of LUNR can be described as rather expensive.
Based on the Price/Forward Earnings ratio, LUNR is valued a bit cheaper than the industry average as 65.67% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.34, LUNR is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 24.81
LUNR Price Earnings VS Forward Price EarningsLUNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LUNR Per share dataLUNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

LUNR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LUNR's earnings are expected to grow with 22.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.69%
EPS Next 3Y22.46%

0

5. Dividend

5.1 Amount

LUNR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTUITIVE MACHINES INC

NASDAQ:LUNR (8/15/2025, 8:00:00 PM)

After market: 9.0898 +0 (+0.05%)

9.085

+0.1 (+1.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)N/A N/A
Inst Owners47.67%
Inst Owner Change3.34%
Ins Owners3.55%
Ins Owner Change-1.49%
Market Cap1.62B
Analysts76
Price Target15.41 (69.62%)
Short Float %17.41%
Short Ratio2.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1364.82%
Min EPS beat(2)-2702.77%
Max EPS beat(2)-26.87%
EPS beat(4)1
Avg EPS beat(4)-774.06%
Min EPS beat(4)-2702.77%
Max EPS beat(4)211.5%
EPS beat(8)4
Avg EPS beat(8)-342.97%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.42%
Min Revenue beat(2)-4.93%
Max Revenue beat(2)-3.91%
Revenue beat(4)1
Avg Revenue beat(4)-2.27%
Min Revenue beat(4)-12.88%
Max Revenue beat(4)12.66%
Revenue beat(8)3
Avg Revenue beat(8)-8.07%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.9%
PT rev (3m)1.71%
EPS NQ rev (1m)-103.8%
EPS NQ rev (3m)97.08%
EPS NY rev (1m)0%
EPS NY rev (3m)174%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)-2.7%
Revenue NY rev (1m)0.25%
Revenue NY rev (3m)-1.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 24.81
P/S 5.59
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.59
EYN/A
EPS(NY)0.37
Fwd EY4.03%
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS1.63
BVpS-0.73
TBVpS-0.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -59.17%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.25%
FCFM N/A
ROA(3y)-6.39%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 708.17%
Cap/Sales 5.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.39
Quick Ratio 4.39
Altman-Z 2.21
F-Score4
WACC10.11%
ROIC/WACCN/A
Cap/Depr(3y)1417.1%
Cap/Depr(5y)N/A
Cap/Sales(3y)20.38%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-307.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-175.86%
EPS Next Y103.64%
EPS Next 2Y43.69%
EPS Next 3Y22.46%
EPS Next 5Y16.43%
Revenue 1Y (TTM)186.72%
Revenue growth 3Y46.48%
Revenue growth 5YN/A
Sales Q2Q%21.51%
Revenue Next Year17.83%
Revenue Next 2Y29.49%
Revenue Next 3Y23.57%
Revenue Next 5Y23.87%
EBIT growth 1Y-33.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year73.58%
EBIT Next 3Y42.49%
EBIT Next 5Y38.36%
FCF growth 1Y-151.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-615.87%
OCF growth 3YN/A
OCF growth 5YN/A